<DOC>
	<DOCNO>NCT00857038</DOCNO>
	<brief_summary>COPD progressive pulmonary disease characterize inflammatory process airway lung lead progressive airway obstruction . The inflammation associate tissue loss remodelling . The investigator hypothesize doxycycline reduces neutrophilic airway inflammation patient COPD . Therefore investigator conduct randomize trial doxycycline 30 patient .</brief_summary>
	<brief_title>Doxycycline Airway Inflammation Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>Rationale : COPD disease characterize chronic inflammation irreversible airway obstruction . Chronic inflammation lead degradation extracellular matrix hereby destruction lung parenchyma . Tetracyclines know anti-inflammatory property diseases rheumatoid arthritis . Objective : To assess effect doxycycline marker neutrophilic inflammation proteolytic activity induce sputum stable GOLD II III COPD patient . Study population : Thirty patient stable GOLD II COPD . Intervention : Placebo versus doxycycline randomise design .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>GOLD II III COPD ( GOLD II : FEV1/FVC &lt; 70 % ; 50 % &lt; FEV1 &lt; 80 % predict , GOLD III : FEV1/FVC &lt; 70 % ; 30 % &lt; FEV1 &lt; 50 % predict ) . Stable disease ( exacerbation last 3 month ) . Age &gt; 40 yr . Written informed consent . Infections and/or use antibiotic last month . Bacterial colonization airway , proven sputum culture bronchoalveolar lavage ( BAL ) . Allergy tetracycline history substantial sideeffects . Active respiratory disease COPD ( e.g . sarcoidosis , tuberculosis , lung cancer , bronchiectasis ) . Acute exacerbation COPD define Anthonisen et al . [ 10 ] . Signs and/or symptom current respiratory nonrespiratory infection . Use oral intravenous corticosteroid immunosuppressive drug within last month .</criteria>
	<gender>All</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>COPD</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Neutrophilic</keyword>
	<keyword>Myeloperoxidase</keyword>
	<keyword>Doxycycline</keyword>
</DOC>